(Q34876135)

5 August 2017

1 reference

title

CD8+ T-cell immunity to HIV infection (English)

1 reference

5 August 2017

Paolo Piazza

1

1 reference

5 August 2017

Zheng Fan

series ordinal

2

1 reference

5 August 2017

Charles R Rinaldo

series ordinal

3

1 reference

5 August 2017

publication date

1 September 2002

1 reference

Clinics in laboratory medicine

5 August 2017

published in

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

773-797

1 reference

Extensive variation of human immunodeficiency virus type-1 in vivo

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Accessing complexity: the dynamics of virus-specific T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HLA-peptide tetrameric complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-1 receptors and cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Anti-HIV Type 1 Cytotoxic T Lymphocyte Effector Activity and Disease Progression in the First 8 Years of HIV Type 1 Infection of Homosexual Men

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

The importance of the innate immune system in controlling HIV infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Viral subversion of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Quantifying the uncertainty in forecasts of anthropogenic climate change

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

A Single Residue Exchange Within a Viral CTL Epitope Alters Proteasome-Mediated Degradation Resulting in Lack of Antigen Presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Repression of MHC class I gene promoter activity by two-exon Tat of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Long-term nonprogression in HIV infection: methodological issues and scientific priorities. Report of an international European community-National Institutes of Health Workshop, The Royal Society, London, England, November 27-29, 1995. Scientific Co

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Frequency and function of HIV-specific CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

1 reference

7 January 2021

Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Changes in Frequency of HIV‐1–Specific Cytotoxic T Cell Precursors and Circulating Effectors after Combination Antiretroviral Therapy in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Structured treatment interruptions for the management of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Control of SIV rebound through structured treatment interruptions during early infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Challenges and opportunities for development of an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Cellular HIV-1 immune responses in natural infection and after genetic immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

One step forwards, one step back

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

HIV-specific cytotoxic T lymphocytes in seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Protection from pathogenic SIV challenge using multigenic DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2802%2900006-9

7 January 2021

10.1016/S0272-2712(02)00006-9

Identifiers

DOI

1 reference

5 August 2017

1 reference